Abstract
The utilization of appropriate transfusion therapy is a vital aspect in the prevention of morbidity in pediatric oncology patients. Practitioners must be cognizant of the risks and benefits of transfusion as well as the appropriate transfusion practices in immunocompromised patients. Here we review the evidence regarding transfusion management practices in pediatric cancer patients with anemia, thrombocytopenia and neutropenia as well as practice in managing potential transfusion reactions. Where an evidence basis is lacking, we review consensus guidelines in both the pediatric and adult cohorts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal AK, Hastings CH, Feusner J (2011) Hematologic supportive care in children with cancer. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 6th edn. Lippincott Williams and Wilkins, Philadelphia
Agrawal AK, Hsu E, Quirolo K et al (2012) Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary. Pediatr Blood Cancer 58:466–468
Alessandrino EP, Della Porta MG, Bacigalupo A et al (2010) Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 95:476–484
Almeida-Porada GD, Ascensao JL (1996) Cytomegalovirus as a cause of pancytopenia. Leuk Lymphoma 21:217–223
Alpert G, Fleisher GR (1984) Complications of infection with Epstein-Barr virus during childhood: a study of children admitted to the hospital. Pediatr Infect Dis 3:304–307
Anderson KC, Goodnough LT, Sayers M et al (1991) Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 77:2096–2102
Andreu G (2009) Transfusion-associated circulatory overload and transfusion-related acute lung injury: diagnosis, pathophysiology, management and prevention. ISBT Sci Ser 4:63–71
Angelucci E, Brittenham GM, McLaren CE et al (2000) Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 343:327–331
Arduino MJ, Bland LA, Tipple MA et al (1989) Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes. J Clin Microbiol 27:1483–1485
Armand P, Kim HT, Cutler CS et al (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:4586–4588
Athale UH, Chan AK (2007) Hemorrhagic complications in pediatric hematologic malignancies. Semin Thromb Hemost 33:408–415
Ballas SK (2001) Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 38:30–36
Barrera R, Mina B, Huang Y et al (1996) Acute complications of central line placement in profoundly thrombocytopenic cancer patients. Cancer 78:2025–2030
Barrett NA, Kam PC (2006) Transfusion-related acute lung injury: a literature review. Anesthesia 61:777–785
Belt RJ, Leite C, Haas CD, Stephens RL (1978) Incidence of hemorrhagic complications in patients with cancer. JAMA 239:2571–2574
Benjamin RJ, Anderson KS (2002) What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit Rev Oncol Hematol 42:163–171
Bishton M, Chopra R (2004) The role of granulocyte transfusions in neutropenic patients. Br J Haematol 127:501–508
Blajchman MA, Goldman M, Freedman JJ, Sher GD (2001) Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus Med Rev 15:1–20
Blumberg N, Fine L, Gettings KF, Heal JM (2005) Decreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions. Transfusion 45:1632–1639
Bolton-Maggs PH, Murphy MF (2004) Blood transfusion. Arch Dis Child 89:4–7
Bowden RA, Slichter SJ, Sayers M et al (1995) A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 86:3598–3603
British Committee for Standards in Hematology (BCSH) (2003) Guidelines on the use of platelet transfusions. Br J Haematol 122:10–23
Brittenham GM, Sheth S, Allen CJ et al (2001) Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 38:37–56
Buchanan GR (2005) Blood transfusions in children with cancer and hematologic disorders: why, when, and how? Pediatr Blood Cancer 44:114–116
Bürger B, Zimmermann M, Mann G et al (2003) Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 21:184–188
Busch MP, Glynn SA, Stramer SL (2005) A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45:254–264
Carr R, Hutton JL, Jenkins JA et al (1990) Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 75:408–413
Cazzola M (2000) Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin. Med Oncol 17:S11–S16
Cazzola M, Malcovati L (2005) Myelodysplastic syndromes—coping with ineffective hematopoiesis. N Engl J Med 352:536–538
Chanock SJ, Gorlin JB (1996) Granulocyte transfusions. Time for a second look. Infect Dis Clin North Am 10:327–343
Chu RW (1999) Leukocytes in blood transfusion: adverse effects and their prevention. Hong Kong Med J 5:280–284
Church GD, Price C, Sanchez R (2006) Transfusion-related acute lung injury in the paediatric patient: two case reports and a review of the literature. Transfus Med 16:343–348
Coit DB, Turnbull AD (1988) A safe technique for the placement of implantable vascular access devices in patients with thrombocytopenia. Surg Gynecol Obstet 167:429–431
Consensus Conference (1987) Platelet transfusion therapy. JAMA 257:1777–1780
Contreras M (1998) The appropriate use of platelets: an update from the Edinburgh Consensus Conference. Br J Haematol 101:10–12
Couban S, Carruthers J, Andreou P et al (2002) Platelet transfusion in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion 42:753–758
Cunningham RS (2003) Anemia in the oncology patient: cognitive function and cancer. Cancer Nurs 26:38S–42S
Darbari DS, Kple-Faget P, Kwagyan J et al (2006) Circumstances of death in adult sickle cell disease patients. Am J Hematol 81:858–863
Davies SC, Kinsey SE (1994) Clinical aspects of paediatric blood transfusion: cellular components. Vox Sang 67:50–53
Davies P, Robertson S, Hedge S et al (2007) Calculating the required transfusion volume in children. Transfusion 47:212–216
De Ville de Goyet M, Moniotte S, Robert A et al (2013) Iron overload in children undergoing cancer treatments. Pediatr Blood Cancer 60:1982–1987
Dodd RY (2007) Current risk for transfusion transmitted infections. Curr Opin Hematol 14:671–676
Doerfler ME, Kaufman B, Goldenberg AS (1996) Central venous catheter placement in patients with disorders of hemostasis. Chest 110:185–188
Duquesnoy RJ, Filip DJ, Rodey GE et al (1977) Successful transfusion of platelets “mis-matched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 2:219–226
Dutcher JP, Schiffer CA, Aisner J et al (1981) Alloimmunization following platelet transfusion: the absence of a dose–response relationship. Blood 57:395–398
Dwyre DM, Holland PV (2008) Transfusion-associated graft-versus-host disease. Vox Sang 95:85–93
Dwyre DM, Fernando LP, Holland PV (2011) Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 100:92–98
Dzik WH (2002) Leukoreduction of blood components. Curr Opin Hematol 9:521–526
Eder AF, Herron R, Strupp A et al (2007) Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47:599–607
Eid AJ, Brown RA, Patel R, Razonable RR (2006) Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 43:40–48
El-Mahallawy HA, Mansour T, El-Din SE et al (2004) Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy. J Pediatr Hematol Oncol 26:403–406
Emy PY, Levin TL, Sheth SS et al (1997) Iron overload in reticuloendothelial systems of pediatric oncology patients who have undergone transfusions: MR observations. Am J Radiol 168:1011–1015
Eng J, Fish JD (2011) Insidious iron burden in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 56:368–371
Fasano R, Luban NL (2008) Blood component therapy. Pediatr Clin North Am 55:421–455
Fenaux P, Rose C (2009) Impact of iron overload in myelodysplastic syndromes. Blood Rev 23:S15–S19
Fischer R, Tiemann ED, Engelhardt R et al (1999) Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry. Am J Hematol 60:289–299
Friedberg RC, Donnelly SF, Boyd JC et al (1993) Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 81:3428–3434
Friedberg RC, Donnelly SF, Mintz PD (1994) Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients. Transfusion 34:215–220
Friedmann AM, Sengul H, Lehmann H et al (2002) Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev 16:34–45
Gajjar A, Harrison PL, Sandlund JT et al (2000) Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood 96:3381–3384
Garcia-Manero G, Shan J, Faderl S et al (2008) A prognostic score for patients with low risk myelodysplastic syndrome. Leukemia 22:538–543
Gauvin F, Lacroix J, Robillard P et al (2006) Acute transfusion reactions in the pediatric intensive care unit. Transfusion 46:1899–1908
Geiger TL, Howard SC (2007) Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev 21:1–12
Gelb AB, Leavitt AD (1997) Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 37:624–630
Gibson BE, Todd A, Roberts I et al (2004) Transfusion guidelines for neonates and older children. Br J Haematol 124:433–453
Glatstein M, Oron T, Barak M et al (2005) Posttransfusion equilibration of hematocrit in hemodynamically stable neonates. Pediatr Crit Care Med 6:707–708
Gmür J, Burger J, Schanz U et al (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 338:1223–1226
Goldman M, Webert KE, Arnold DM et al (2005) Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 19:2–31
Green DM, Breslow NE, Beckwith JB et al (1998) Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 16:237–245
Grigull L, Pulver N, Goudeva L et al (2006) G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 14:910–916
Groopman JE, Itri LM (1999) Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91:1616–1634
Guyatt G, Gutterman D, Baumann MH et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 129:174–181
Halonen P, Mattila J, Suominen P et al (2003) Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics 111:91–96
Heal JM, Blumberg N, Masel D (1987) An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 70:23–30
Heckman KD, Weiner GJ, Davis CS et al (1997) Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 15:1143–1149
Heddle NM (2004) Universal leukoreduction and acute transfusion reactions: putting the puzzle together. Transfusion 44:1–4
Heddle NM, Klama LN, Griffith L et al (1993) A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusion. Transfusion 33:794–797
Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM (1994) Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 34:929–934
Hockenberry MJ, Hinds PS, Barrera P et al (2002) Incidence of anemia in children with solid tumors or Hodgkin disease. J Pediatr Hematol Oncol 24:35–37
Hockenberry-Eaton M, Hinds PS (2000) Fatigue in children and adolescents with cancer: evolution of a program of study. Semin Oncol Nurs 16:261–272
Howard JE, Perkins HA (1978) The natural history of alloimmunization to platelets. Transfusion 18:496–503
Howard SC, Gajjar AC, Ribeiro RC et al (2000) Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 284:2222–2224
Howard SC, Gajjar AC, Cheng C et al (2002) Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemia. JAMA 288:2001–2007
Jayabose S, Tugal O, Ruddy R et al (1993) Transfusion therapy for severe anemia. Am J Pediatr Hematol Oncol 15:324–327
Kaur P, Basu S (2005) Transfusion-transmitted infections: existing and emerging pathogens. J Postgrad Med 51:146–151
Kennedy LD, Case LD, Hurd DD et al (2008) A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion 48:2285–2291
Kickler TS, Ness PM, Baine HG (1988) Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient. Am J Clin Pathol 90:69–72
King KE, Shirey RS, Thoman SK et al (2004) Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 44:25–29
Klein HG, Strauss RG, Schiffer CA (1996) Granulocyte transfusion therapy. Semin Hematol 33:359–368
Klein HG, Dodd RY, Ness PM et al (1997) Current status of microbial contamination of blood components: summary of a conference. Transfusion 37:95–101
Kleinman S, Caulfield T, Chan P et al (2004) Towards an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44:1774–1789
Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116:11S–26S
Kuehnert MJ, Roth VR, Haley NR et al (2001) Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 41:1493–1499
Linden JV, Wagner K, Voytovich AE et al (2000) Transfusion errors in New York state: an analysis of 10 years’ experience. Transfusion 40:1207–1213
Ljungman P (2004) Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction. Br J Haematol 125:107–116
Loh AH, Chui CH (2007) Port-A-Cath insertions in acute leukemia: dose thrombocytopenia affect morbidity? J Pediatr Surg 42:1180–1184
Lowell JA, Bothe A Jr (1991) Venous access. Preoperative, operative, and postoperative dilemmas. Surg Clin North Am 71:1231–1246
Luban NL, Drothler D, Moroff G et al (2000) Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 40:348–352
Malcovati L, Della Porta MG, Cazzola M (2006) Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. Haematologica 91:1588–1590
Marec-Berard P, Blay JY, Schell M et al (2003) Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients. J Clin Oncol 21:4235–4238
Massey E, Paulus U, Doree C et al (2009) Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev (1):CD005341
Michon J (2002) Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol 39:448–450
Mock V, Olsen M (2003) Current management of fatigue and anemia in patients with cancer. Semin Oncol Nurs 19:36–41
Moroff G, Luban NL (1992) Prevention of transfusion-associated graft-versus-host disease. Transfusion 32:102–103
Morrow JF, Braine HG, Kickler TS et al (1991) Septic reactions to platelet transfusions. A persistent problem. JAMA 266:555–558
Myhre BA, McRuer D (2000) Human error—a significant cause of transfusion mortality. Transfusion 40:879–885
Nachman J, Sather HN, Cherlow JM et al (1998) Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children’s Cancer Group. J Clin Oncol 16:920–930
Nash T, Hoffmann S, Butch S et al (2012) Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients. Transfusion 52:2270–2272
Nichols WG, Price TH, Gooley T et al (2003) Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 101:4195–4200
Norfolk DR, Ancliffe PJ, Contreras M et al (1998) Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27–28 November 1997. Synopsis of background papers. Br J Haematol 101:609–617
Norville R, Hinds P, Wilimas J et al (1997) The effects of infusion rate on platelet outcomes and patient responses in children with cancer: an in vitro and in vivo study. Oncol Nurs Forum 24:1789–1793
O’Connell BA, Lee EJ, Rothko K et al (1992) Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood 79:527–531
Paglino JC, Pomper GJ, Fisch GS et al (2004) Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 44:16–24
Peters C (2009) Granulocyte transfusions in neutropenic patients: beneficial effects proven? Vox Sang 96:275–283
Popovsky MA (2000) Transfusion-related acute lung injury. Curr Opin Hematol 7:402–407
Ray CE Jr, Shenoy SS (1997) Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 204:97–99
Rebulla P (2001) Platelet transfusion trigger in difficult patients. Transfus Clin Biol 8:249–254
Rebulla P, Finazzi G, Marangoni F et al (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto. N Engl J Med 337:1870–1875
Rintels PB, Kenney RM, Crowley JP (1994) Therapeutic support of the patient with thrombocytopenia. Hematol Oncol Clin North Am 8:1131–1157
Robinson SP, Marks DI (2004) Granulocyte transfusion in the G-CSF era. Where do we stand? Bone Marrow Transplant 34:839–846
Roseff SD, Luban NL, Manno CS (2002) Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42:1398–1413
Rossetto CL, McMahon JE (2000) Current and future trends in transfusion therapy. J Pediatr Oncol Nurs 17:160–170
Rubin RH, Tolkoff-Rubin NE, Oliver D et al (1985) Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40:243–249
Ruccione KS, Midambi K, Sposto R et al (2012) Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatr Blood Cancer 59:697–702
Ruggiero A, Riccardi R (2002) Interventions for anemia in pediatric cancer patients. Med Pediatr Oncol 39:451–454
Rühl H, Bein G, Sachs UJ (2009) Transfusion-associated graft-versus-host disease. Transfus Med Rev 23:62–71
Sachs UJ, Reiter A, Walter T et al (2006) Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion 46:1909–1914
Sanchez R, Toy P (2005) Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 45:248–255
Sanders RP, Maddirala SD, Geiger TL et al (2005) Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 130:781–787
Schiffer CA (1991) Prevention of alloimmunization against platelets. Blood 77:1–4
Schiffer CA, Lee EJ, Ness PM et al (1986) Clinical evaluation of platelet concentrates stored for one to five days. Blood 67:1591–1594
Schiffer CA, Anderson KC, Bennett CL et al (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1519–1538
Schrezenmeier H, Walther-Wenke G, Müller TH et al (2007) Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 47:644–652
Seidel MG, Peters C, Wacker A et al (2008) Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 42:679–684
Shander A, Cappellini MD, Goodnough LT (2009) Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang 97:185–197
Silliman CC, Boshkov LK, Mehdizadehkashi Z et al (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101:454–462
Slichter SJ, Harker LA (1978) Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 7:523–539
Sobrero A, Puglisi F, Guglielmi A et al (2001) Fatigue: a main component of anemia symptomatology. Semin Oncol 28:15–18
St Pierre TG, Clark PR, Chau-anusorn W et al (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105:855–861
Stainsby D, Jones H, Asher D et al (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20:273–282
Stasi R, Abriani L, Beccaglia P et al (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98:1786–1801
Stellato TA, Gauderer MW, Lazarus HM et al (1985) Percutaneous silastic catheter insertion in patients with thrombocytopenia. Cancer 56:2691–2693
Strauss RG, Barnes A Jr, Blanchette VS et al (1990) Directed and limited-exposure blood donations for infants and children. Transfusion 30:68–72
Tas F, Eralp Y, Basaran M et al (2002) Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol 25:371–379
te Loo DM, Kamps WA, van der Does-van den Berg A et al (2006) Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. J Clin Oncol 24:2332–2336
The Trial to Reduce Alloimmunization to Platelets Study Group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 337:1861–1869
Thiele T, Krüger W, Zimmermann K et al (2011) Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME). Transfusion 51:2620–2626
Vamvakas EC (2005) Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 19:181–199
Vamvakas EC, Blajchman MA (2001) Universal WBC reduction: the case for and against. Transfusion 41:691–712
Vamvakas ED, Pineda AA (1997) Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apher 12:74–81
van de Wetering MD, Weggelaar N, Offinga M et al (2007) Granulocyte transfusions in neutropaenic children: a systematic review of the literature. Eur J Cancer 43:2082–2092
van Marwijk Kooy M, van Prooijen HC, Moes M et al (1991) Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood 77:201–205
Wagner S (1997) Transfusion-related bacterial sepsis. Curr Opin Hematol 4:464–469
Wandt H, Frank M, Ehninger G et al (1998) Safety and cost effectiveness of a 103 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 203 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91:3601–3606
Wang SE, Lara PN, Lee-Ow A et al (2002) Acetaminophen and diphenhydramine as premedication for platelet transfusions: a prospective randomized double-blind placebo-controlled trial. Am J Hematol 70:191–194
Welch HG, Larson EB, Slichter SJ (1989) Providing platelets for refractory patients. Prudent strategies. Transfusion 29:193–195
Williamson LM, Lowe S, Love EM et al (1999) Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 319:16–19
Wong EC, Perez-Albuerne E, Moscow JA, Luban NL (2005) Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists. Pediatr Blood Cancer 44:119–127
Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460–1465
Yazer MH, Podlosky L, Clarke G, Nahirniak SM (2004) The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 44:10–15
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Gomez, E., Agrawal, A.K., Hastings, C.A. (2015). Transfusion Support. In: Feusner, J., Hastings, C., Agrawal, A. (eds) Supportive Care in Pediatric Oncology. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44317-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-44317-0_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44316-3
Online ISBN: 978-3-662-44317-0
eBook Packages: MedicineMedicine (R0)